Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC.
Jiaqi XuLujuan WangNa YinAnqi ChenJunqi YiJingqun TangJuanjuan XiangPublished in: Thoracic cancer (2021)
Lipoproteins enriched in EVPs reflect the activated lipid metabolism in dormant cancer cells and may provide potential biomarkers or therapeutic targets for cisplatin-based therapy.